Cytiva - Model Xuri IL-2 - Cell Therapy Growth Factor
From Cell Therapy Technologies - Xuri Growth Factors
Clinical manufacturing-grade formulation available in vials or syringes. For use in cell therapy applications.
Product Details
Interleukin-2 available in two formats – powder or liquid. This growth factor reliably activates T lymphocytes for efficient cell expansion. Meets USPfor cell therapy ancillary material as applicable to supplier.
- Gain peace of mind. Produced under a certified GMP license regularly qualified by licensing authorities. Sterility- and endotoxin-tested according to USP.
- Reproducible. No need to revalidate each new lot.
- Manage contamination risk. Easily connect Xuri IL-2 Syringe to a bag via Luer connection.
Functionality of this product is based on biological activity assays. Animal component-free. All Xuri reagents and media are compatible with Xuri Cell Expansion System.
Interleukin-2 promotes the growth, activity and maintenance of T and B lymphocytes. IL-2 is key in a number of cell and cell-based gene therapies.
Regulatory supportRegulatory support file (RSF) is available.
Quality statementXuri growth factors are manufactured, tested, and released in compliance with relevant cGMP guidelines. USP Chapter ‹1043› ‘Ancillary materials for cell, gene and tissue-engineered products’ has been followed in the design of these products.
Product Specifications
Parameter: Xuri IL-2 (1 mg)
- Activity Range1: 11.5 - 26.0 MIU/mg
- Certificate of Analysis: Yes
- Endotoxin Activity Max.: < 25 EU/mg
- Molecular Weight (Mr): 14 - 16 kDa
- Physical Form: Powder
- Purity: ≥ 95%
- Stability2: 24 months
- Storage conditions: 2-8°C
- Pack size: 10 µg
1Powder tested prior to lyophilization; liquid tested after filling
2Real-time stability studies for liquid are ongoing, with expected shelf life of at least 24 months
Downloads related to this product
Customer reviews
No reviews were found for Cytiva - Model Xuri IL-2 - Cell Therapy Growth Factor. Be the first to review!